{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T17:21:02Z","timestamp":1778520062774,"version":"3.51.4"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-025-04048-x","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:13:00Z","timestamp":1761041580000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["MED15-TFE3 rearranged renal cell carcinoma: a subtype of TFE3-rearranged renal cell carcinoma with unique clinicopathologic features and better prognosis"],"prefix":"10.1186","volume":"23","author":[{"given":"Zhenggen","family":"Deng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanhao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enjia","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaopo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongqian","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weidong","family":"Gan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,21]]},"reference":[{"issue":"1","key":"4048_CR1","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.eururo.2016.02.029","volume":"70","author":"H Moch","year":"2016","unstructured":"Moch H, Cubilla AL, Humphrey PA, Reuter VE, Ulbright TM. The 2016 WHO classification of tumours of the urinary system and male genital Organs-Part A: Renal, Penile, and testicular tumours. Eur Urol. 2016;70(1):93\u2013105.","journal-title":"Eur Urol"},{"issue":"5","key":"4048_CR2","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.eururo.2022.06.016","volume":"82","author":"H Moch","year":"2022","unstructured":"Moch H, Amin MB, Berney DM, Comp\u00e9rat EM, Gill AJ, Hartmann A, Menon S, Raspollini MR, Rubin MA, Srigley JR, et al. The 2022 world health organization classification of tumors of the urinary system and male genital Organs-Part A: Renal, Penile, and testicular tumors. Eur Urol. 2022;82(5):458\u201368.","journal-title":"Eur Urol"},{"issue":"3","key":"4048_CR3","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/PAP.0000000000000332","volume":"29","author":"MS Tretiakova","year":"2022","unstructured":"Tretiakova MS. Chameleon TFE3-translocation RCC and how gene partners can change morphology: accurate diagnosis using contemporary modalities. Adv Anat Pathol. 2022;29(3):131\u201340.","journal-title":"Adv Anat Pathol"},{"key":"4048_CR4","doi-asserted-by":"publisher","first-page":"1116648","DOI":"10.3389\/fonc.2023.1116648","volume":"13","author":"W Guo","year":"2023","unstructured":"Guo W, Zhu Y, Pu X, Guo H, Gan W. Clinical and pathological heterogeneity of four common fusion subtypes in Xp11.2 translocation renal cell carcinoma. Front Oncol. 2023;13:1116648.","journal-title":"Front Oncol"},{"issue":"1","key":"4048_CR5","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.molcel.2022.12.013","volume":"83","author":"C Nardone","year":"2023","unstructured":"Nardone C, Palanski BA, Scott DC, Timms RT, Barber KW, Gu X, Mao A, Leng Y, Watson EV, Schulman BA, et al. A central role for regulated protein stability in the control of TFE3 and MITF by nutrients. Mol Cell. 2023;83(1):57\u2013e7359.","journal-title":"Mol Cell"},{"issue":"18","key":"4048_CR6","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1038\/sj.onc.1201394","volume":"15","author":"J Clark","year":"1997","unstructured":"Clark J, Lu YJ, Sidhar SK, Parker C, Gill S, Smedley D, Hamoudi R, Linehan WM, Shipley J, Cooper CS. Fusion of splicing factor genes PSF and NonO (p54nrb) to the TFE3 gene in papillary renal cell carcinoma. Oncogene. 1997;15(18):2233\u20139.","journal-title":"Oncogene"},{"issue":"1","key":"4048_CR7","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12894-016-0154-6","volume":"16","author":"X Cheng","year":"2016","unstructured":"Cheng X, Gan W, Zhang G, Li X, Guo H. Clinical characteristics of XP11.2 translocation\/TFE3 gene fusion renal cell carcinoma: a systematic review and meta-analysis of observational studies. BMC Urol. 2016;16(1):40.","journal-title":"BMC Urol"},{"key":"4048_CR8","doi-asserted-by":"publisher","first-page":"784993","DOI":"10.3389\/fonc.2021.784993","volume":"11","author":"Y Ge","year":"2021","unstructured":"Ge Y, Lin X, Zhang Q, Lin D, Luo L, Wang H, Li Z. Xp11.2 translocation renal cell carcinoma with TFE3 rearrangement: distinct morphological features and prognosis with different fusion partners. Front Oncol. 2021;11:784993.","journal-title":"Front Oncol"},{"issue":"34","key":"4048_CR9","doi-asserted-by":"publisher","first-page":"5374","DOI":"10.1038\/sj.onc.1206686","volume":"22","author":"P Argani","year":"2003","unstructured":"Argani P, Lui MY, Couturier J, Bouvier R, Fournet JC, Ladanyi M. A novel CLTC-TFE3 gene fusion in pediatric renal adenocarcinoma with t(X;17)(p11.2;q23). Oncogene. 2003;22(34):5374\u20138.","journal-title":"Oncogene"},{"issue":"8","key":"4048_CR10","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1002\/gcc.22261","volume":"54","author":"W Huang","year":"2015","unstructured":"Huang W, Goldfischer M, Babayeva S, Mao Y, Volyanskyy K, Dimitrova N, Fallon JT, Zhong M. Identification of a novel PARP14-TFE3 gene fusion from 10-year-old FFPE tissue by RNA-seq. Genes Chromosomes Cancer. 2015;54(8):500\u20135.","journal-title":"Genes Chromosomes Cancer"},{"issue":"5","key":"4048_CR11","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1097\/PAS.0000000000000835","volume":"41","author":"P Argani","year":"2017","unstructured":"Argani P, Zhang L, Reuter VE, Tickoo SK, Antonescu CR. RBM10-TFE3 renal cell carcinoma: A potential diagnostic pitfall due to cryptic intrachromosomal Xp11.2 inversion resulting in False-negative TFE3 FISH. Am J Surg Pathol. 2017;41(5):655\u201362.","journal-title":"Am J Surg Pathol"},{"key":"4048_CR12","doi-asserted-by":"crossref","unstructured":"Cali\u00f2 A, Segala D, Munari E, Brunelli M, Martignoni G. MiT family translocation renal cell carcinoma: from the early descriptions to the current knowledge. Cancers (Basel). 2019;11(8):1110.","DOI":"10.3390\/cancers11081110"},{"issue":"3","key":"4048_CR13","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00428-018-2509-8","volume":"474","author":"H Fukuda","year":"2019","unstructured":"Fukuda H, Kato I, Furuya M, Tanaka R, Takagi T, Kondo T, Nagashima Y. A novel partner of TFE3 in the Xp11 translocation renal cell carcinoma: clinicopathological analyses and detection of EWSR1-TFE3 fusion. Virchows Arch. 2019;474(3):389\u201393.","journal-title":"Virchows Arch"},{"issue":"5","key":"4048_CR14","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/s41379-018-0191-7","volume":"32","author":"J Pei","year":"2019","unstructured":"Pei J, Cooper H, Flieder DB, Talarchek JN, Al-Saleem T, Uzzo RG, Dulaimi E, Patchefsky AS, Testa JR, Wei S. NEAT1-TFE3 and KAT6A-TFE3 renal cell carcinomas, new members of MiT family translocation renal cell carcinoma. Mod Pathol. 2019;32(5):710\u20136.","journal-title":"Mod Pathol"},{"issue":"6","key":"4048_CR15","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/gcc.23127","volume":"62","author":"MA Kuentz","year":"2023","unstructured":"Kuentz MA, Blons H, Gimenez-Roqueplo AP, Just PA, Laurent-Puig P, Mejean A, Oudard S, Verkarre V. A novel VCP::TFE3 gene fusion resulting from t(X;9)(p11.23;p13.3) chromosome translocation in TFE3 rearranged renal cancer cell carcinoma. Genes Chromosomes Cancer. 2023;62(6):361\u20136.","journal-title":"Genes Chromosomes Cancer"},{"issue":"10","key":"4048_CR16","doi-asserted-by":"publisher","first-page":"868","DOI":"10.2174\/0109298665255704230920063254","volume":"30","author":"Z Ren","year":"2023","unstructured":"Ren Z, Zhang X, Han J. Expression and prognostic significance of Ferroptosis-related proteins SLC7A11 and GPX4 in renal cell carcinoma. Protein Pept Lett. 2023;30(10):868\u201376.","journal-title":"Protein Pept Lett"},{"issue":"2","key":"4048_CR17","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/modpathol.2011.169","volume":"25","author":"S Macher-Goeppinger","year":"2012","unstructured":"Macher-Goeppinger S, Roth W, Wagener N, Hohenfellner M, Penzel R, Haferkamp A, Schirmacher P, Aulmann S. Molecular heterogeneity of TFE3 activation in renal cell carcinomas. Mod Pathol. 2012;25(2):308\u201315.","journal-title":"Mod Pathol"},{"issue":"12","key":"4048_CR18","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1097\/00000478-200212000-00003","volume":"26","author":"P Argani","year":"2002","unstructured":"Argani P, Antonescu CR, Couturier J, Fournet JC, Sciot R, Debiec-Rychter M, Hutchinson B, Reuter VE, Boccon-Gibod L, Timmons C, et al. PRCC-TFE3 renal carcinomas: morphologic, immunohistochemical, ultrastructural, and molecular analysis of an entity associated with the t(X;1)(p11.2;q21). Am J Surg Pathol. 2002;26(12):1553\u201366.","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"4048_CR19","first-page":"e37072","volume":"15","author":"P Kalita","year":"2023","unstructured":"Kalita P, Dey B, Saurabh A, Chishti SF. Xp11.2 translocation renal cell carcinoma: A rare renal cell carcinoma. Cureus. 2023;15(4):e37072.","journal-title":"Cureus"},{"issue":"3","key":"4048_CR20","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1136\/jclinpath-2020-206681","volume":"74","author":"Y Song","year":"2021","unstructured":"Song Y, Yin X, Xia Q, Zheng L, Yao J, Zeng H, Nie L, Gong J, Zhou Q, Chen N. Xp11 translocation renal cell carcinoma with morphological features mimicking multilocular cystic renal neoplasm of low malignant potential: a series of six cases with molecular analysis. J Clin Pathol. 2021;74(3):171\u20136.","journal-title":"J Clin Pathol"},{"issue":"7","key":"4048_CR21","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1002\/cncr.23331","volume":"112","author":"JI Geller","year":"2008","unstructured":"Geller JI, Argani P, Adeniran A, Hampton E, De Marzo A, Hicks J, Collins MH. Translocation renal cell carcinoma: lack of negative impact due to lymph node spread. Cancer. 2008;112(7):1607\u201316.","journal-title":"Cancer"},{"issue":"1","key":"4048_CR22","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12894-022-01060-1","volume":"22","author":"J Zhou","year":"2022","unstructured":"Zhou J, Zhao L, Yang Z, Chen Y, Wu X, Xue W. Clinicopathologic, treatment and prognosis study of 46 Xp11.2 translocation\/TFE3 gene fusion renal cell carcinomas. BMC Urol. 2022;22(1):109.","journal-title":"BMC Urol"},{"key":"4048_CR23","doi-asserted-by":"crossref","unstructured":"Simonaggio A, Ambrosetti D, Verkarre V, Auvray M, Oudard S, Vano YA. MiTF\/TFE translocation renal cell carcinomas: from clinical entities to molecular insights. Int J Mol Sci. 2022;23(14):7649.","DOI":"10.3390\/ijms23147649"},{"issue":"11","key":"4048_CR24","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1097\/PAS.0000000000000927","volume":"41","author":"T Antic","year":"2017","unstructured":"Antic T, Taxy JB, Alikhan M, Segal J. Melanotic translocation renal cell carcinoma with a novel ARID1B-TFE3 gene fusion. Am J Surg Pathol. 2017;41(11):1576\u201380.","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"4048_CR25","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1177\/10668969221108517","volume":"31","author":"M Kmeid","year":"2023","unstructured":"Kmeid M, Akgul M. TFE3 rearrangement and expression in renal cell carcinoma. Int J Surg Pathol. 2023;31(5):509\u201320.","journal-title":"Int J Surg Pathol"},{"key":"4048_CR26","doi-asserted-by":"crossref","unstructured":"Huang Z, Du Y, Yin H, Wang G, Xu T. Inhibition of canonical Wnt signaling in renal cell carcinoma bone metastasis: an immunohistochemical analysis of DKK1 and LRP5 expression. Protein Pept Lett. 2025;32(5):327\u201334.","DOI":"10.2174\/0109298665357331250416081850"},{"key":"4048_CR27","doi-asserted-by":"publisher","unstructured":"Vlachostergios PJ, Karathanasis A, Karasavvidou F, Tzortzis V. Association of KIM-1 (HAVCR1) expression with the tumor immune microenvironment in clear cell renal cell carcinoma. Curr Gene Ther. 2025. https:\/\/doi.org\/10.2174\/0115665232402424250721114133.","DOI":"10.2174\/0115665232402424250721114133"},{"issue":"1","key":"4048_CR28","doi-asserted-by":"publisher","first-page":"135","DOI":"10.4103\/ijpm.ijpm_755_21","volume":"66","author":"T Xia","year":"2023","unstructured":"Xia T, Long H, Liao D, Wang W, Xiao X. A case of TFE3 translocation renal cell carcinoma with rare morphological features and literature review. Indian J Pathol Microbiol. 2023;66(1):135\u201340.","journal-title":"Indian J Pathol Microbiol"},{"issue":"5","key":"4048_CR29","doi-asserted-by":"publisher","first-page":"212","DOI":"10.5582\/ddt.2014.01036","volume":"8","author":"T Nakatsubo","year":"2014","unstructured":"Nakatsubo T, Nishitani S, Kikuchi Y, Iida S, Yamada K, Tanaka A, Ohkuma Y. Human mediator subunit MED15 promotes transcriptional activation. Drug Discov Ther. 2014;8(5):212\u20137.","journal-title":"Drug Discov Ther"},{"issue":"1","key":"4048_CR30","doi-asserted-by":"publisher","first-page":"5262","DOI":"10.1038\/s41467-021-25618-z","volume":"12","author":"G Sun","year":"2021","unstructured":"Sun G, Chen J, Liang J, Yin X, Zhang M, Yao J, He N, Armstrong CM, Zheng L, Zhang X, et al. Integrated exome and RNA sequencing of TFE3-translocation renal cell carcinoma. Nat Commun. 2021;12(1):5262.","journal-title":"Nat Commun"},{"issue":"1","key":"4048_CR31","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M, Gingeras TR. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29(1):15\u201321.","journal-title":"Bioinformatics"},{"issue":"1","key":"4048_CR32","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nbt.1754","volume":"29","author":"JT Robinson","year":"2011","unstructured":"Robinson JT, Thorvaldsd\u00f3ttir H, Winckler W, Guttman M, Lander ES, Getz G, Mesirov JP. Integrative genomics viewer. Nat Biotechnol. 2011;29(1):24\u20136.","journal-title":"Nat Biotechnol"},{"issue":"9","key":"4048_CR33","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1093\/hmg\/5.9.1333","volume":"5","author":"SK Sidhar","year":"1996","unstructured":"Sidhar SK, Clark J, Gill S, Hamoudi R, Crew AJ, Gwilliam R, Ross M, Linehan WM, Birdsall S, Shipley J, et al. The t(X;1)(p11.2;q21.2) translocation in papillary renal cell carcinoma fuses a novel gene PRCC to the TFE3 transcription factor gene. Hum Mol Genet. 1996;5(9):1333\u20138.","journal-title":"Hum Mol Genet"},{"issue":"6","key":"4048_CR34","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/modpathol.2013.208","volume":"27","author":"CL Ellis","year":"2014","unstructured":"Ellis CL, Eble JN, Subhawong AP, Martignoni G, Zhong M, Ladanyi M, Epstein JI, Netto GJ, Argani P. Clinical heterogeneity of Xp11 translocation renal cell carcinoma: impact of fusion subtype, age, and stage. Mod Pathol. 2014;27(6):875\u201386.","journal-title":"Mod Pathol"},{"issue":"6","key":"4048_CR35","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1093\/ajcp\/aqad089","volume":"160","author":"XM Wang","year":"2023","unstructured":"Wang XM, Shao L, Xiao H, Myers JL, Pantanowitz L, Skala SL, Udager AM, Vaishampayan U, Mannan R, Dhanasekaran SM, et al. Lessons from 801 clinical TFE3\/TFEB fluorescence in situ hybridization assays performed on renal cell carcinoma suspicious for MiTF family aberrations. Am J Clin Pathol. 2023;160(6):549\u201354.","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"4048_CR36","doi-asserted-by":"publisher","first-page":"839","DOI":"10.3233\/CBM-170757","volume":"21","author":"R Weiten","year":"2018","unstructured":"Weiten R, M\u00fcller T, Schmidt D, Steiner S, Kristiansen G, M\u00fcller SC, Ellinger J, Syring I. The mediator complex subunit MED15, a promoter of tumor progression and metastatic spread in renal cell carcinoma. Cancer Biomark. 2018;21(4):839\u201347.","journal-title":"Cancer Biomark"},{"issue":"1","key":"4048_CR37","doi-asserted-by":"publisher","first-page":"110190","DOI":"10.1016\/j.celrep.2021.110190","volume":"38","author":"Z Bakouny","year":"2022","unstructured":"Bakouny Z, Sadagopan A, Ravi P, Metaferia NY, Li J, AbuHammad S, Tang S, Denize T, Garner ER, Gao X, et al. Integrative clinical and molecular characterization of translocation renal cell carcinoma. Cell Rep. 2022;38(1):110190.","journal-title":"Cell Rep"},{"issue":"1","key":"4048_CR38","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1093\/ajcp\/aqae011","volume":"162","author":"X Yin","year":"2024","unstructured":"Yin X, Hu X, Xu J, Xiong D, Zhao M. MED15::TFE3 fusion renal cell carcinoma with extensive cystic change: A clinicopathologic and molecular genetic study of 2 cases, with an emphasis on differential diagnosis. Am J Clin Pathol. 2024;162(1):86\u201394.","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"4048_CR39","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12894-020-00696-1","volume":"20","author":"W Zhuang","year":"2020","unstructured":"Zhuang W, Liu N, Guo H, Zhang C, Gan W. Gender difference analysis of Xp11.2 translocation renal cell carcinomas\u2019s attack rate: a meta-analysis and systematic review. BMC Urol. 2020;20(1):130.","journal-title":"BMC Urol"},{"issue":"5","key":"4048_CR40","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1097\/PAS.0b013e31824dd972","volume":"36","author":"WR Sukov","year":"2012","unstructured":"Sukov WR, Hodge JC, Lohse CM, Leibovich BC, Thompson RH, Pearce KE, Wiktor AE, Cheville JC. TFE3 rearrangements in adult renal cell carcinoma: clinical and pathologic features with outcome in a large series of consecutively treated patients. Am J Surg Pathol. 2012;36(5):663\u201370.","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"4048_CR41","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1097\/PAP.0000000000000420","volume":"31","author":"Q Cai","year":"2024","unstructured":"Cai Q, Gagan J, Koduru P, Cadeddu J, Shah RB, Kapur P, Palsgrove DN. Multicystic clear cell renal tumors with Low-grade nuclear features: time to include TFE3 Translocation-associated carcinomas. Adv Anat Pathol. 2024;31(1):34\u201342.","journal-title":"Adv Anat Pathol"},{"key":"4048_CR42","doi-asserted-by":"publisher","first-page":"105783","DOI":"10.1016\/j.humpath.2025.105783","volume":"158","author":"A Mladenovic","year":"2025","unstructured":"Mladenovic A, Harik LR, Deeb KK, Genega EM, Saeed F, Gandhi JS. TFE3\/TFEB altered renal cell carcinomas in end-stage renal disease setting: A single institution clinicopathological study of 4 cases. Hum Pathol. 2025;158:105783.","journal-title":"Hum Pathol"},{"issue":"5","key":"4048_CR43","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1111\/his.15304","volume":"85","author":"A Agaimy","year":"2024","unstructured":"Agaimy A, Acosta AM, Cheng L, Collins K, Fridman E, Schubart C, Williamson SR, Hartmann A, Trpkov K. TFE3-rearranged nonmelanotic renal pecoma: a case series expanding their phenotypic and fusion landscape. Histopathology. 2024;85(5):783\u201393.","journal-title":"Histopathology"},{"issue":"1","key":"4048_CR44","first-page":"16","volume":"54","author":"XT Wang","year":"2025","unstructured":"Wang XT, Zhang RS, Li R, Wang X, Fang R, Xia QY, Rao Q. [MED15-TFE3 renal cell carcinoma: a clinicopathological and molecular analysis]. Zhonghua Bing Li Xue Za Zhi. 2025;54(1):16\u201322.","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"issue":"7","key":"4048_CR45","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1097\/PAS.0b013e318293d872","volume":"37","author":"CC Pan","year":"2013","unstructured":"Pan CC, Sung MT, Huang HY, Yeh KT. High chromosomal copy number alterations in Xp11 translocation renal cell carcinomas detected by array comparative genomic hybridization are associated with aggressive behavior. Am J Surg Pathol. 2013;37(7):1116\u20139.","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"4048_CR46","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1016\/j.jpedsurg.2017.03.052","volume":"52","author":"C Liu","year":"2017","unstructured":"Liu C, Zhang W, Song H. Nephron-sparing surgery in the treatment of pediatric renal cell carcinoma associated with Xp11.2 translocation\/TFE3 gene fusions. J Pediatr Surg. 2017;52(9):1492\u20135.","journal-title":"J Pediatr Surg"},{"key":"4048_CR47","doi-asserted-by":"crossref","unstructured":"Dong J, Xu W, Ji Z, Pan B. Xp11.2 Translocation Renal Cell Carcinoma: Clinical Characteristics and Potential Prognostic Predictors. Dis Markers 2021;2021:5647933.","DOI":"10.1155\/2021\/5647933"},{"issue":"1","key":"4048_CR48","doi-asserted-by":"publisher","first-page":"132","DOI":"10.4103\/jcrt.jcrt_1505_22","volume":"19","author":"H Dong","year":"2023","unstructured":"Dong H, Ni Y, Liu Z, Wang Z, Hu B, Xu H, Cai S. Imaging findings, clinical and pathological characters of 28 patients with Xp11.2\/TFE3 translocation renal cell carcinoma. J Cancer Res Ther. 2023;19(1):132\u201340.","journal-title":"J Cancer Res Ther"},{"issue":"1","key":"4048_CR49","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1038\/s41467-020-15671-5","volume":"11","author":"J Cheng","year":"2020","unstructured":"Cheng J, Han Z, Mehra R, Shao W, Cheng M, Feng Q, Ni D, Huang K, Cheng L, Zhang J. Computational analysis of pathological images enables a better diagnosis of TFE3 Xp11.2 translocation renal cell carcinoma. Nat Commun. 2020;11(1):1778.","journal-title":"Nat Commun"},{"issue":"5","key":"4048_CR50","doi-asserted-by":"publisher","first-page":"e16076","DOI":"10.1016\/j.heliyon.2023.e16076","volume":"9","author":"J Lin","year":"2023","unstructured":"Lin J, Tang Z, Zhang C, Dong W, Liu Y, Huang H, Liu H, Huang J, Lin T, Chen X. TFE3 gene rearrangement and protein expression contribute to a poor prognosis of renal cell carcinoma. Heliyon. 2023;9(5):e16076.","journal-title":"Heliyon"},{"issue":"7","key":"4048_CR51","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1002\/cncr.20548","volume":"101","author":"JI Geller","year":"2004","unstructured":"Geller JI, Dome JS. Local lymph node involvement does not predict poor outcome in pediatric renal cell carcinoma. Cancer. 2004;101(7):1575\u201383.","journal-title":"Cancer"},{"issue":"2","key":"4048_CR52","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s00330-016-4421-4","volume":"27","author":"X Chen","year":"2017","unstructured":"Chen X, Zhu Q, Li B, Cui W, Zhou H, Duan N, Liu Y, Kundra V, Wang Z. Renal cell carcinoma associated with Xp11.2 translocation\/TFE gene fusion: imaging findings in 21 patients. Eur Radiol. 2017;27(2):543\u201352.","journal-title":"Eur Radiol"},{"issue":"11","key":"4048_CR53","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1002\/jum.15951","volume":"41","author":"W Ma","year":"2022","unstructured":"Ma W, Zhang F, Huang H, Wang W, Zhu Y, Lu Y, Guo H, Gan W. Contrast-Enhanced ultrasound features of adult Xp11.2 translocation renal cell carcinoma: differential diagnosis with three main renal cell carcinoma subtypes. J Ultrasound Med. 2022;41(11):2673\u201385.","journal-title":"J Ultrasound Med"},{"key":"4048_CR54","doi-asserted-by":"publisher","first-page":"5974089","DOI":"10.1155\/2019\/5974089","volume":"2019","author":"H Ye","year":"2019","unstructured":"Ye H, Qin S, Li N, Lin M, Xu Y, Li X. A rare partner of TFE3 in the Xp11 translocation renal cell carcinoma: clinicopathological analyses and detection of MED15-TFE3 fusion. Biomed Res Int. 2019;2019:5974089.","journal-title":"Biomed Res Int"},{"key":"4048_CR55","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.humpath.2023.03.008","volume":"136","author":"K Doytcheva","year":"2023","unstructured":"Doytcheva K, Gallan AJ, Wang P, Wanjari P, Segal J, Antic T. Cystic MED15::TFE3 translocation renal cell carcinoma: histologic mimicker of multilocular cystic renal neoplasm of low malignant potential with review of the literature. Hum Pathol. 2023;136:25\u201333.","journal-title":"Hum Pathol"},{"issue":"10","key":"4048_CR56","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1038\/modpathol.2011.93","volume":"24","author":"G Martignoni","year":"2011","unstructured":"Martignoni G, Gobbo S, Camparo P, Brunelli M, Munari E, Segala D, Pea M, Bonetti F, Illei PB, Netto GJ, et al. Differential expression of cathepsin K in neoplasms harboring TFE3 gene fusions. Mod Pathol. 2011;24(10):1313\u20139.","journal-title":"Mod Pathol"},{"issue":"6","key":"4048_CR57","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s00428-022-03380-x","volume":"481","author":"A Cali\u00f2","year":"2022","unstructured":"Cali\u00f2 A, Marletta S, Brunelli M, Pedron S, Portillo SC, Segala D, Bariani E, Gobbo S, Netto G, Martignoni G. TFE3 and TFEB-rearranged renal cell carcinomas: an immunohistochemical panel to differentiate from common renal cell neoplasms. Virchows Arch. 2022;481(6):877\u201391.","journal-title":"Virchows Arch"},{"key":"4048_CR58","doi-asserted-by":"publisher","unstructured":"Gan W, Dong X, Guo W, Zhou P, Pan J, Guo H. MED15-TFE3 renal cell carcinoma: a Xp11 translocation renal cell carcinoma subtype with distinct clinicopathological features and superior prognosis. 2022. preprint at https:\/\/doi.org\/10.21203\/rs.3.rs-1255663\/v1.","DOI":"10.21203\/rs.3.rs-1255663\/v1"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-04048-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-025-04048-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-04048-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:05:31Z","timestamp":1761087931000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-025-04048-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4048"],"URL":"https:\/\/doi.org\/10.1186\/s12957-025-04048-x","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,21]]},"assertion":[{"value":"30 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocol for this research project was approved by the institutional review board of Nanjing Drum Tower Hospital. Owing to the retrospective nature of the study, informed consent was waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"385"}}